SCHEMBL5033926

SCHEMBL5033926

CCOC(=O)[C@@H](C)S(=O)(=O)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
ALDH1A1 P00352 4/20 0.37
TRPA1 O75762 1/20 0.37
CA12 O43570 3/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 3/20 0.36
HSD17B10 Q99714 2/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
ALOX15 P16050 1/20 0.34
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
SOAT1 P35610 1/20 0.34
HPGD P15428 1/20 0.33
MMP8 P22894 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5038572 1.00 POLB (0.47) POLBALDH1A1TRPA1CA12CA1
SCHEMBL17953209 0.77 CA14 (0.30)
Trifluoromethanesulfonic Acid SCHEMBL27373538 0.76 POLB (0.38) POLBALDH1A1TRPA1CA12CA1
SCHEMBL2436938 0.76 POLB (0.42) POLBALDH1A1TRPA1HSD17B10LMNA
SCHEMBL1621178 0.76 ALDH1A1 (0.42) POLBALDH1A1TRPA1CA12CA1
SCHEMBL5771 0.76 ALDH1A1 (0.42) POLBALDH1A1TRPA1CA12CA1
SCHEMBL2015431 0.76 ALDH1A1 (0.42) POLBALDH1A1TRPA1CA12CA1
SCHEMBL324716 0.75 POLB (0.38) POLBALDH1A1HSD17B10LMNASMN1; SMN2
SCHEMBL324715 0.75 POLB (0.38) POLBALDH1A1HSD17B10LMNASMN1; SMN2
SCHEMBL701746 0.75 POLB (0.38) POLBALDH1A1HSD17B10LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312220-A1 Oxadiazole Derivatives with Crth2 Receptor Activity 7TM PHARMA A/S (DK) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312220-A1 Oxadiazole Derivatives with Crth2 Receptor Activity HRH2, HRH1, HRH3 POLB 3736/4885ALDH1A1 1905/4885TRPA1 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.